Internal Medicine · Naples, FL
NPI
1003096587
Since 2007
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
800 Goodlette Rd Ste 200
Naples, FL, 34102
Phone (239) 302-3300
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$852K
12,904 prescriptions
Company payments, 2025
$1,169
From 17 companies
Medicare prescription drug claims, 2024
In 2024, the drug Manrique O Iriarte prescribed most often to Medicare patients was Atorvastatin Calcium, with 841 prescriptions and refills. In total Manrique O Iriarte wrote 12,904 Medicare prescriptions that cost $852K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-08-26.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 841 | 2,507 | 318 | $6,508 |
| Metformin Hcl Generic | 533 | 1,582 | 203 | $613 |
| Losartan Potassium Generic | 485 | 1,427 | 187 | $1,518 |
| Rosuvastatin Calcium Generic | 468 | 1,381 | 173 | $3,831 |
| Amlodipine Besylate Generic | 352 | 1,054 | 138 | $355 |
| Lisinopril Generic | 313 | 937 | 122 | $479 |
| Levothyroxine Sodium Generic | 304 | 876 | 109 | $5,077 |
| Carvedilol Generic | 250 | 716 | 81 | $3,034 |
| Tamsulosin Hcl Generic | 224 | 645 | 77 | $1,395 |
| Gabapentin Generic | 221 | 590 | 88 | $5,052 |
| Pantoprazole Sodium Generic | 219 | 635 | 89 | $4,637 |
| Metoprolol Succinate Generic | 215 | 628 | 80 | $3,393 |
| Tradjenta Linagliptin | 195 | 197 | 29 | $98K |
| Xarelto Rivaroxaban | 184 | 184 | 31 | $99K |
| Glipizide Generic | 176 | 507 | 74 | $509 |
Brand drugs: 1,642 claims; generic drugs: 11,053 claims; opioid claims: 22.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Manrique O Iriarte $1,169 ($1,169 in general payments such as food, travel and fees) from 17 companies. The largest payer was Amgen Inc. with $259.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 14 | $259 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $177 |
| Lilly USA, LLC LLY | 6 | $126 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $85.99 |
| Pfizer Inc. PFE | 3 | $65.27 |
| Novo Nordisk Inc NVO | 3 | $65.09 |
| Esperion Therapeutics, Inc. ESPR | 3 | $60.34 |
| Radius Health, Inc. | 2 | $51.89 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $46.27 |
| Inspire Medical Systems, Inc. INSP | 1 | $44.1 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.